Patrick Truesdell
Nessuna posizione attualmente
Patrimonio netto: - $ in data 30/04/2024
Profilo
Patrick Truesdell served as Chief Accounting Officer, VP & Controller at Landos Biopharma, Inc. from 2022 to 2023.
Prior to that, he was Vice President-Finance & Controller at Gemini Therapeutics, Inc. from 2021 to 2022.
Truesdell received a graduate degree from the University of Illinois and undergraduate and MBA degrees from Tippie College of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
LANDOS BIOPHARMA, INC.
-.--% | 31/03/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Precedenti posizioni note di Patrick Truesdell
| Società | Posizione | Fine |
|---|---|---|
| LANDOS BIOPHARMA, INC. | Contatto Relazioni con gli Investitori | 10/11/2023 |
| GEMI THER | Comptroller/Controller/Auditor | 01/04/2022 |
Formazione di Patrick Truesdell
| Tippie College of Business | Masters Business Admin |
| University of Illinois | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| LANDOS BIOPHARMA, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Gemini Therapeutics, Inc.
 Gemini Therapeutics, Inc. BiotechnologyHealth Technology Gemini Therapeutics, Inc. is a clinical-stage precision medicine company. It is developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration. The company was founded by Johanna Seddon, Paul Barlow and Andrew Herbert on March 3, 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Patrick Truesdell
